Cataflam (diclofenac potassium) is a nonsteroidal anti-inflammatory drug (NSAID). Diclofenac works by reducing substances in the body that cause pain and inflammation.
Cataflam is used to treat mild to moderate pain, or signs and symptoms of osteoarthritis or rheumatoid arthritis.
Cataflam is also used to treat menstrual cramps.
Important information
Cataflam can increase your risk of fatal heart attack or stroke, especially if you use it long term or take high doses, or if you have heart disease. Even people without heart disease or risk factors could have a stroke or heart attack while taking this medicine. Do not use Cataflam just before or after heart bypass surgery (coronary artery bypass graft, or CABG).
Diclofenac may also cause stomach or intestinal bleeding, which can be fatal. These conditions can occur without warning while you are using Cataflam, especially in older adults.
How should I take Cataflam?
Take Cataflam exactly as directed on the label, or as prescribed by your doctor. Your doctor may occasionally change your dose. Do not take this medicine in larger amounts or for longer than recommended. Use the lowest dose that is effective in treating your condition.
For treatment of pain or primary dysmenorrhea the recommended dosage of Cataflam is 50 mg three times daily. In some patients an initial dose of 100 mg of Cataflam, followed by 50 mg doses, may provide better relief.
For the relief of osteoarthritis the recommended dosage of Cataflam is 100-150 mg/day in divided doses, i.e. 50 mg two or three times a day.
For the relief of rheumatoid arthritis the recommended dosage is 150-200 mg/day in divided doses, i.e. 50 mg three or four times a day.
If you use Cataflam long-term, you may need frequent medical tests.
Store at room temperature away from moisture and heat.
-
6 hours
-
Anti-Inflammatory
-
50-200 mg/day
-
No
-
No
-
Possible
-
No
-
No
Add a Review
Your email address will not be published. Required fields are marked *
Submit a Photo
Your email address will not be published. Required fields are marked *